This grant supports research to optimize and advance genomic and biologic therapies for Alzheimer’s-related dementias, from preclinical development through early clinical evaluation.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
This grant supports academic and biotech researchers in developing new drugs to prevent, slow, or treat Alzheimer’s disease through preclinical and early-stage clinical research.
Funding for Alzheimer's drug development from pre-clinical to Phase I clinical trials to prevent, slow, or treat AD symptoms, excluding basic research and non-pharmacological interventions.
This grant supports research to identify and validate new, modifiable therapeutic targets for improving central nervous system outcomes in people with HIV using patient data and innovative models.